Papers
21
Total Citations
918
H-Index
12
About
Christopher Eden is a distinguished urological surgeon and researcher whose work has fundamentally shaped the field of minimally invasive urological surgery, with particular expertise in robot-assisted and laparoscopic approaches to prostate cancer and urological reconstruction. His most cited work, a 2013 systematic review and meta-analysis on ureteropelvic junction obstruction repair (266 citations), demonstrated his command of comparative surgical outcomes research, while a landmark multinational study examining positive surgical margin rates across over 22,000 prostatectomy patients (151 citations) provided critical guidance for surgical best practices globally. Eden has been a pioneering advocate for the Retzius-sparing robot-assisted radical prostatectomy technique, producing multiple influential studies examining its functional outcomes, learning curve across three continents, and salvage applications — collectively advancing its adoption worldwide. His contributions extend to patient safety, including an early multi-institutional study on thromboembolic complications (146 citations), and to frontier oncology through the TRoMbone trial exploring radical prostatectomy in oligo-metastatic prostate cancer. His 2025 review on single-port robotic surgery confirms his continued relevance at the cutting edge of urological innovation. With hundreds of citations across a decade of consistent output, Eden remains an authoritative voice shaping modern urological surgical practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9The current landscape of single-port robotic surgery in urology22 citations · 2025
- 10